Mechanisms of peripheral microvascular dysfunction in transgenic mice overexpressing the Alzheimer's disease amyloid Aβ protein

Journal of Alzheimer's Disease

Volumn 4, Issue 6, 2002, Pages 467-478

  Khalil, Zeinab ^a,d   Poliviou, Helen ^a   Maynard, Christa J ^a,b   Beyreuther, Konrad ^c   Masters, Colin L ^a,b   Li, Qiao Xin ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

Author keywords

Alzheimer's disease; Amyloid peptide; Endothelial cell function; Endothelin; Reactive oxygen species; Skin microvasculature; Transgenic mouse

Indexed keywords

ACETYLCHOLINE; AMYLOID A PROTEIN; AMYLOID BETA PROTEIN; CATALASE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); NITROPRUSSIDE SODIUM; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; LASER DOPPLER FLOWMETRY; MALE; MICROANGIOPATHY; MICROVASCULATURE; MOUSE; NONHUMAN; PERIPHERAL MICROVASCULAR DYSFUNCTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; VASOCONSTRICTION; VASODILATATION;

EID: 0036970023     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2002-4603     Document Type: Article

References (37)

1. L. Perlmutter and H. Chui, Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review, Brain Res Bull. 24 (1990), 677-686.
2. C. Zarow, E. Abrron, H. Chui and L. Perlmutter, Vascular basement membrane pathology and Alzheimer's disease, Ann. N. Y Acad. Sci. 26 (1997), 147-160.
3. L.S. Perlmutter, Microvascular pathology and vascular basement membrane components in Alzheimer's disease, Mol Neurobiol. 9 (1994), 33-40.
4. M. Bell and M. Ball, Morphometric comparison of hippocampal microvasculature in ageing and demented people: diameters and densities, Acta neuropathol. 53 (1981), 299-318.
5. P.B. Eisenhauer, R.J. Johnson, J.M. Wells, T.A. Davies and R.E. Fine, Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of dutch-type mutant, J. Neurosci. Res. 60 (2000), 804-810.
6. X. Chi, E.T. Sutton, G. Hellermann and J.M. Price, Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells, Neurosci Lett. 290 (2000), 9-12.
7. Z. Khalil, K. Sanderson, P. Isberg, M. Bassirat, B. Livett and R. Helme, βA4(25-35) modulates substance P effect on rat skin microvasculature in aged rats: pharmacological manipulation using SEC receptor ligands, Brain Res. 651 (1994), 227-235.
8. Z. Khalil, H. Chen and R. Helme, Mechanisms underlying the vascular activity of beta-amyloid protein fragment (βA(4)25-35) at the level of skin microvasculature, Brain Res. 736 (1996), 206-216.
9. T. Thomas, E. Sutton, A. Hellermann and J. Price, β-amyloid-induced coronary artery vasoactivity and endothelial damage, J Cardiovasc Pharmacol. 30 (1997), 517-522.
10. F. Crawford, Z. Suo, C. Fang and M. Mullan, β-Amyloid peptides and enhancement of vasoconstriction by endothelin-1, Ann. N. Y. Acad. Sci. 826 (1997), 461-462.
11. T. Thomas, C. McLendon, E. Sutton and G. Thomas, Cerebrovascular endothelial dysfunction mediated by β-amyloid, Neuroreport 8 (1997), 1387-1391.
12. T. Thomas, C. McLendon, E. Sutton and G. Thomas, β- Amyloid-induced cerebrovascular endothelial dysfunction, Ann. N.Y. Acad. Sci. 826 (1997), 447-451.
13. J. Price, E. Sutton, A. Hellermann and T. Thomas, β-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain, Neurol Res. 19 (1997), 534-538.
14. Z. Suo, J. Humphrey, A. Kundtz, F. Sethi, A. Placzek, F. Crawford and M. Mullan, Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo, Neuroscience Lett. 257 (1998), 77-88.
15. H. Poliviou and Z. Khalil, β-amyloid protein fragments modulate the vascular activity of Substance P at the level of the microvasculature, Alzheimer's Reports 1 (1998), 33-40.
16. H. Poliviou and Z. Khalil, β-amyloid protein modulates the vascular activity of acetylcholine at the level of the skin microvasculature, Alzheimer's Reports 1 (1998), 233-239.
17. H. Poliviou and Z. Khalil, Involvement of endothelial and nonendothelial mechanisms in the vasoconstrictor activity of Aβ, Alzheimer's Reports 2 (1999), 105-112.
18. E. Sutton, G. Hellermann and T. Thomas, β-amyloid-induced endothelial necrosis and inhibition of nitric oxide production, Exp Cell Res. 230 (1997), 368-376.
19. Q.X. Li, C. Maynard, R. Cappai, C.A. McLean, R.A. Cherny, T. Lynch, J.G. Culvenor, J. Trevaskis, J.E. Tanner, K.A. Bailey, C. Czech, A.I. Bush, K. Beyreuther and C.L. Masters, Intracellular accumulation of amyloidgenic Aβ fragment of AD precursor protein in the hippocampus of aged transgenic mice, J. Neurochem. 72 (1999), 2479-2487.
20. M. Kawai, R.N. Kalaria, P. Cras, S.L. Siedlak, M.E. Velasco, E.R. Shelton, H.W. Chan, B.D. Greenberg and G. Perry, Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer's disease. Brain Res. 623 (1993), 142-146.
21. A. Kammesheidt, F.M. Boyce, A.F. Spanoyannis, B.J. Cummings, M. Ortegon, C. Cotman, J.L. Vaught and R.L. Neve, Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of Alzheimer amyloid precursor in the brain, Proc. Natl. Acad. Sci. USA 89 (1992), 10857-10861
22. F.A. Sandhu, Y. Kim, K.A. Lapan, M. Salim, V. Aliuddin and S.B. Zain, Expression of the C terminus of the amyloid precursor protein alters growth factor responsiveness in stably transfected PC12 cells, Proc. Natl. Acad. Sci. USA 93 (1996), 2180-2185.
23. F. Zhang, C. Eckman, S. Younkin, K.K. Hsiao and C. Iadecola, Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein, J. Neurosci. 17 (1997), 7655-7661.
24. C. Iadecola, F. Zhang, K. Niwa, C. Eckman, S.K. Turner, E. Fischer, S. Younkin, D.R. Borchelt, K.K. Hsiao and G.A. Carlson, SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein, Nature Neurosci. 2 (1999), 157-161.
25. E. Masliah, C.E. Westland, E.M. Rockenstein, C.R. Abraham, M. Mallory, I. Veinberg, E. Sheldon and L. Mucke, Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo, Neurosci. 78 (1997), 135-146.
26. C.S. Atwood, X. Huang, R.D. Tanzi and A. Bush, Role of free radical and metal ions in the pathogenisis of Alzheimer's disease, Met. Ions. Biol. Syst. 36 (1999), 309-364.
27. M.A. Smith, K. Hirai, K. Hsiao, M.A. Pappolla, P. Harris, S. Siedlak, M. Tabaton and G. Perry, Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress, J. Neurochem. 70 (1998), 2212-2215.
28. M. Cuajungco, L. Goldstein, A. Nunomura, M.A. Smith, J.T. Lim, C.S. Atwood, X. Huang, Y.W. Farrag, G. Perry and A.I. Bush, Evidence that the β-Amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc, J. Biol. Chem. 275 (2000), 19439-19442.
29. X. Huang, M.P. Cajungco, G. Atwood, M.A. Hartshorn, J.D. Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E. Goldstein, R.C. Scarpa, A.J. Saunders, J. Lim, R.D. Moir, C. Glabe, E.F. Bowden, C.L. Masters, D.P. Fairlie, R.E. Tanzi and A.I. Bush, Cu(II) potentiation of Alzheimer Aβ neurotoxicity correlation with cell-free hydrogen peroxide production and metal reduction, J. Biol. Chem. 274 (1999), 37111-37116.
30. M. Harris, J. Carney, P. Cole, K. Hensley, B.J. Howard, L. Martin, P. Bummer, Y. Wang, Jr. N.W. Pedigo and D.A. Butterfield, Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease, Neuroreport 6 (1995), 1875-1879.
31. K. Hensley, M. Aksenova, J.A. Carney, M. Harris and B.A. Butterfield, Amyloid beta-peptide spin trapping. I: Peptide enzyme toxicity is related to free radical spin trap reactivity, Neuroreport 6 (1995), 489-492.
32. K. Hensley, M. Aksenova, J.A. Carney, M. Harris and B.A. Butterfield, Amyloid beta-peptide spin trapping, II: Evidence for decomposition of the PBN spin adduct, Neuroreport 6 (1995), 493-496.
33. B. Halliwel, Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disese, Alzheimer's disease, trumatic injury or stroke? Acta Neurol. Scand. Suppl. 126 (1989), 23-33.
34. D. Paris, T. Town, T. Parker, J. Tan, J. Humphrey, F. Crawford and M. Mullan, Inhibition of Alzheimer's β-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism, Exp. Neurol. 157 (1999), 211-221.
35. M.P. Mattson, B.Cheng, D. Davis, K. Bryant, I. Lieberburg and R.E. Rydel, Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J Neurosci. 12 (1992), 376-389.
36. M. Mattson, K. Tomaselli and R. Rydel, Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by Basic FGF, Brain Res. 62 (1993), 135-149.
37. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture, J Neurochem. 62 (1994), 372-375.